Patents for C12R 1 - Micro-organisms (92,025) |
---|
04/13/1995 | WO1995009610A1 Liposomes containing particulate materials |
04/13/1995 | WO1995007991A3 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
04/12/1995 | EP0647718A1 Genetic fingerprinting of yeasts |
04/12/1995 | EP0647715A1 Genetic engineering of novel plant phenotypes |
04/12/1995 | EP0647711A1 Plants transformed with a DNA sequence from bacillus thuringiensis lethal to lepidoptera |
04/12/1995 | EP0647280A1 Over expression of single-stranded molecules |
04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
04/12/1995 | EP0647273A1 Dna sequences encoding oligosaccharide transporter |
04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
04/12/1995 | EP0647268A1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
04/12/1995 | EP0568546B1 Bridged cyclic ketal derivatives |
04/12/1995 | EP0567554B1 Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
04/12/1995 | EP0478696B1 Efficient method for identifiable expression of non-selectable genes |
04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
04/12/1995 | EP0357672B1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
04/11/1995 | US5405945 DNA encoding reproductive hormones and expression using a minigene |
04/11/1995 | US5405941 Gene therapy; anticancer, antiinflammatory agents, autoimmune diseases, Alzheimers*s |
04/11/1995 | US5405777 Acetic acid assimilating gene and a method for preventing accumulation of acetic acid in culture medium |
04/11/1995 | US5405772 Medium for long-term proliferation and development of cells |
04/11/1995 | US5405768 Genetic engineering |
04/11/1995 | US5405767 Adding a carboxylic acid, salt or ester to facilitate precipitation |
04/11/1995 | US5405759 Heparitinase, process for producing the same and bacteria producing the same |
04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
04/11/1995 | CA1335182C Cellulose binding fusion proteins |
04/11/1995 | CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies |
04/06/1995 | WO1995009243A1 METHOD OF PRODUCING α,α-TREHALOSE |
04/06/1995 | WO1995009242A1 Production of novel carbohydrate with improved plastid initial |
04/06/1995 | WO1995009238A1 High level expression of human cyclooxygenase-2 |
04/06/1995 | WO1995009233A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
04/06/1995 | WO1995009231A1 Insulin-secreting cell lines, methods of production and use |
04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
04/06/1995 | WO1995009182A1 Protective antigens against parasites |
04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
04/06/1995 | WO1995008998A1 Compositions for the prevention and treatment of viral-induced tumors |
04/06/1995 | CA2172997A1 Insulin-secreting cell lines, methods of production and use |
04/06/1995 | CA2172611A1 High level expression of human cyclooxygenase-2 |
04/06/1995 | CA2172492A1 Protective antigens against parasites |
04/06/1995 | CA2172261A1 Compositions for the prevention and treatment of viral-induced tumors |
04/06/1995 | CA2170986A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
04/06/1995 | CA2150256A1 Method of producing .alpha.,.alpha.-trehalose |
04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
04/05/1995 | EP0646793A2 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
04/05/1995 | EP0646649A1 Method of producing iturin A and antifungal agent for profund mycosis |
04/05/1995 | EP0646646A2 Protein expression system |
04/05/1995 | EP0646645A2 A process for producing a substance |
04/05/1995 | EP0646644A2 Periplasmic membrane-bound system for detecting protein-protein interactions |
04/05/1995 | EP0646641A2 Method of stabilizing preparation for contact lenses |
04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
04/05/1995 | EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
04/05/1995 | EP0646177A1 HETEROLOGOUS GENE EXPRESSION IN $i(BACILLUS SUBTILIS): FUSION APPROACH |
04/05/1995 | EP0646176A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
04/05/1995 | EP0646173A1 Reagent for agglutination assays |
04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
04/05/1995 | EP0646015A1 Contraceptive vaccine |
04/05/1995 | EP0646013A1 Platelet derived growth factor antagonists |
04/05/1995 | EP0645963A1 Fungicidal and insecticidal compounds and compositions derived from fungal strains of pyrenophora teres |
04/05/1995 | EP0549675B1 Detergent containing protease and inhibitor and novel inhibitors for use therein |
04/05/1995 | EP0507839B1 Method of separating haemopoietic progenitor cells |
04/05/1995 | EP0318554B1 Targeted multifunctional proteins |
04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
04/05/1995 | CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein |
04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
04/04/1995 | US5403915 Isolation and purification of lung surfactant protein |
04/04/1995 | US5403739 Method for esterification of (S)-citronellol using lipase in supercritical carbon dioxide |
04/04/1995 | US5403737 Serine protease variants having peptide ligase activity |
04/04/1995 | US5403734 t-PA with growth factor domain substitutions |
04/04/1995 | US5403724 Treating with a culture of Candida solani and isolating the 15-alpha hydroxyprostaglandin intermediate |
04/04/1995 | US5403723 Process for the production of lignolytic enzymes by means of white rot fungi |
04/04/1995 | US5403721 Precipitate test for microorganisms |
04/04/1995 | US5403710 Nucleic acid probes and methods for detecting pathogenic candida yeasts |
04/04/1995 | US5403584 Use of Streptomyces WYEC 108 to control plant pathogens |
04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
04/04/1995 | CA1335083C Fr901228 substance and preparation thereof |
04/03/1995 | EP0672152A4 Fusion proteins comprising mgf and il-3. |
04/02/1995 | CA2137578A1 Method of stabilizing preparations for contact lenses |
03/31/1995 | CA2132937A1 Protein expression system |
03/30/1995 | WO1995008645A1 Isolation and composition of novel glycosidases |
03/30/1995 | WO1995008636A1 Racemate cleavage of primary and secondary amines by enzyme-catalysed acylation |
03/30/1995 | WO1995008632A1 Immunoreactive antigens of hepatitis e virus |
03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof |
03/30/1995 | WO1995008570A1 Chimeric proteins which block complement activation |
03/30/1995 | WO1995008554A1 Nf-at polypeptides and polynucleotides |
03/30/1995 | WO1995008548A1 Recombinant production of novel polyketides |
03/30/1995 | WO1995005472A3 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
03/30/1995 | CA2172610A1 Chimeric proteins which block complement activation |
03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof |